论文部分内容阅读
我科对50例晚期非小细胞肺癌(NSCLC)采用康艾注射液联合化疗与单纯化疗进行比较,在增效减毒方面取得了一定疗效,现报告如下。1资料与方法1.1一般资料:50例均经病理学确诊为NSCLC,根据国际TNM分期标准[1],临床分期Ⅲb~Ⅳ期,KPS评分≥60分。治疗组25例,男性16例,女性9例,年龄34~7
Our department of 50 patients with advanced non-small cell lung cancer (NSCLC) Kangai injection combined with chemotherapy compared with chemotherapy alone, in the efficiency and reduce toxicity has achieved some effect, are as follows. 1 Materials and Methods 1.1 General Information: 50 cases were pathologically confirmed as NSCLC, according to international TNM staging [1], clinical stage Ⅲ b ~ Ⅳ, KPS score ≥ 60 points. The treatment group of 25 cases, 16 males and 9 females, aged 34 to 7